N-Adamantyl-4-methylthiazol-2-amine suppresses amyloid β-induced neuronal oxidative damage in cortical neurons

Free Radical Research

Volumn 50, Issue 6, 2016, Pages 678-690

  Cho, Chang Hun ^a   Kim, Eun A ^b   Kim, Jiae ^a   Choi, Soo Young ^c   Yang, Seung Ju ^b   Cho, Sung Woo ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Konyang University   (South Korea)

^c Hallym University   (South Korea)

Author keywords

Alzheimer s disease; beta amyloid; N adamantyl 4 methylthiazol 2 amine; oxidative stress

Indexed keywords

AMYLOID BETA PROTEIN; CASPASE 3; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; MALONALDEHYDE; N ADAMANTYL 4 METHYLTHIAZO 2 AMINE; NEUROPROTECTIVE AGENT; NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; THIAZOLE DERIVATIVE; UNCLASSIFIED DRUG; ADAMANTANE; N-ADAMANTYL-4-METHYLTHIAZOL-2-AMINE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CELL; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME CONFORMATION; MITOCHONDRIAL MEMBRANE POTENTIAL; NERVE CELL; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; ALZHEIMER DISEASE; ANALOGS AND DERIVATIVES; ANIMAL; METABOLISM; OXIDATION REDUCTION REACTION; SPRAGUE DAWLEY RAT;

ADAMANTANE; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; NEURONS; OXIDATION-REDUCTION; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; THIAZOLES;

EID: 84964478223     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2016.1167277     Document Type: Article

References (71)

1. W.Cerpa, M.C.Dinamarca, N.C.Inestrosa. Structure–function implications in Alzheimer’s disease: effect of Abeta oligomers at central synapses. Curr Alzheimer Res 2008;5:233–243.
2. S.W.Wang, Y.J.Wang, Y.J.Su, W.W.Zhou, S.G.Yang, R.Zhang,. Rutin inhibits β-amyloid aggregation and cytotoxicity, attenuates oxidative stress, and decreases the production of nitric oxide and proinflammatory cytokines. Neurotoxicology 2012;33:482–490.
3. J.F.Flood, J.E.Morley, E.Roberts. Amnestic effects in mice of four synthetic peptides homologous to amyloid beta protein from patients with Alzheimer disease. Proc Natl Acad Sci USA 1991;88:3363–3366.
4. J.Götz, F.Chen, J.Van Dorpe, R.M.Nitsch. Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science 2001;293:1491–1495.
5. M.Zampagni, D.Wright, R.Cascella, G.D’Adamio, F.Casamenti, E.Evangelisti,. Novel S-acyl glutathione derivatives prevent amyloid oxidative stress and cholinergic dysfunction in Alzheimer disease models. Free Radic Biol Med 2012;52:1362–1371.
6. A.Nunomura, G.Perry, G.Aliev, K.Hirai, A.Takeda, E.K.Balraj,. Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 2001;60:759–767.
7. P.I.Moreira, C.Carvalho, X.W.Zhu, M.A.Smith, G.Perry. Mitochondrial dysfunction is a trigger of Alzheimer’s disease pathophysiology. Biochim Biophys Acta 2010;1802:2–10.
8. A.Kern, C.Behl The unsolved relationship of brain aging and late-onset Alzheimer disease. Biochim Biophys Acta 2009;1790:1124–1132.
9. P.H.Reddy, M.F.Beal Are mitochondria critical in the pathogenesis of Alzheimer’s disease? Brain Res Brain Res Rev 2005;49:618–632.
10. V.Chauhan, A.Chauhan. Oxidative stress in Alzheimer’s disease. Pathophysiology 2006;13:195–208.
11. R.Resende, P.I.Moreira, T.Proenca, A.Deshpande, J.Busciglio, C.Pereira,. Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease. Free Radic Biol Med 2008;44:2051–2057.
12. K.T.Akama, C.Albanese, R.G.Pestell, L.J.Van Eldik Amyloid beta-peptide stimulates nitric oxide production in astrocytes through an NFkappaB-dependent mechanism. Proc Natl Acad Sci USA 1998;95:5795–5800.
13. J.G.Masilamoni, E.P.Jesudason, K.S.Jesudoss, J.Murali, S.F.Paul, R.Jayakumar. Role of fibrillar Abeta25–35 in the inflammation induced rat model with respect to oxidative vulnerability. Free Radic Res 2005;39:603–612.
14. M.A.Lovell, W.R.Markesbery. Oxidative damage in mild cognitive impairment and early Alzheimer’s disease. J Neurosci Res 2007;85:3036–3040.
15. V.Heiser, S.Engemann, W.Brocker, I.Dunkel, A.Boeddrich, S.Waelter,. Identification of benzothiazoles as potential polyglutamine aggregation inhibitors of Huntington’s disease by using an automated filter retardation assay. Proc Natl Acad Sci USA 2002;99:16400–16406.
16. T.Ishiyama, R.Okada, H.Nishibe, H.Mitsumoto, C.Nakayama Riluzole slows the progression of neuromuscular dysfunction in the wobbler mouse motor neuron disease. Brain Res 2004;1019:226–236.
17. E.Brantley, S.Antony, G.Kohlhagen, L.H.Meng, K.Agama, S.F.Stinson,. Anti-tumor drug candidate 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole induces single strand breaks and DNA–protein cross-links in sensitive MCF-7 breast cancer cells. Cancer Chemother Pharmacol 2006;58:62–72.
18. C.G.Mortimer, G.Wells, J.P.Crochard, E.L.Stone, T.D.Bradshaw, M.F.Stevens,. Antitumor benzothiazoles. 26.1 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW 610, NSC 721648), a simple fluorinated 2-arylbenzothiazole, shows potent and selective inhibitory activity against lung, colon, and breast cancer cell lines. J Med Chem 2006;49:179–185.
19. N.Pietrancosta, A.Moumen, R.Dono, P.Lingor, V.Planchamp, F.Lamballe,. Iminotetrahydro-benzothiazole derivatives as p53 inhibitors: discovery of a highly potent in vivo inhibitor and its action mechanism. J Med Chem 2006;49:3645–3652.
20. V.K.Gribkoff, M.E.Bozik. KNS-760704 [(6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine dihydrochloride monohydrate] for the treatment of amyotrophic lateral sclerosis. CNS Neurosci Ther 2008;14:215–226.
21. A.Gallardo-Godoy, J.Gever, K.L.Fife, B.M.Silber, S.B.Prusiner, A.R.Renslo 2-Aminothiazoles as therapeutic leads for prion diseases. J Med Chem 2011;54:1010–1021.
22. Z.Li, B.M.Silber, S.Rao, J.R.Gever, C.Bryant, A.Gallardo-Godoy,. 2-Aminothiazoles with improved pharmacotherapeutic properties for treatment of prion disease. ChemMedChem 2013;8:847–857.
23. M.Anzini, A.Chelini, A.Mancini, A.Cappelli, M.Frosini, L.Ricci,. Synthesis and biological evaluation of amidine, guanidine, and thiourea derivatives of 2-amino(6-trifluoromethoxy)benzothiazole as neuroprotective agents potentially useful in brain diseases. J Med Chem 2010;53:734–744.
24. E.A.Kim, A.R.Han, J.Choi, J.Y.Ahn, S.Y.Choi, S.W.Cho Anti-inflammatory mechanisms of N-adamantyl-4-methylthiazol-2-amine in lipopolysaccharide-stimulated BV-2 microglial cells. Int Immunopharmacol 2014;22:73–83.
25. S.J.Yang, W.J.Lee, E.A.Kim, K.D.Nam, H.G.Hahn, S.Y.Choi,. Effects of N-adamantyl-4-methylthiazol-2-amine on hyperglycemia, hyperlipidemia and oxidative stress in streptozotocin-induced diabetic rats. Eur J Pharmacol 2014;736:26–34.
26. W.E.Klunk, Y.Wang, G.F.Huang, M.L.Debnath, D.P.Holt, L.Shao,. The binding of 2-(4′-methylaminophenyl)benzothiazole to postmortem brain homogenates is dominated by the amyloid component. J Neurosci 2003;23:2086–2092.
27. R.Leuma Yona, S.Mazères, P.Faller, E.Gras Thioflavin derivatives as markers for amyloid-beta fibrils: insights into structural features important for high-affinity binding. ChemMedChem 2008;3:63–66.
28. M.M.Choi, E.A.Kim, H.G.Hahn, K.D.Nam, S.J.Yang, S.Y.Choi,. Protective effect of benzothiazole derivative KHG21834 on amyloid beta-induced neurotoxicity in PC12 cells and cortical and mesencephalic neurons. Toxicology 2007;239:156–166.
29. B.M.Nie, X.Y.Jiang, J.X.Cai, S.L.Fu, L.M.Yang, L.Lin,. Panaxydol and panaxynol protect cultured cortical neurons against Abeta25–35-induced toxicity. Neuropharmacology 2008;54:845–853.
30. Z.Feng, J.T.Zhang Melqatonin reduces amyloid β-induced apoptosis in pheochromocytoma (PC12) cells. J Pineal Res 2004;37:257–266.
31. E.A.Kim, J.Choi, A.R.Han, S.Y.Choi, H.G.Hahn, S.W.Cho Anti-oxidative and anti-inflammatory effects of 2-cyclopropylimino-3-methyl-1,3-thiazoline hydrochloride on glutamate-induced neurotoxicity in rat brain. Neurotoxicology 2013;38:106–114.
32. J.K.Youn, D.W.Kim, S.T.Kim, S.Y.Park, E.J.Yeo, Y.J.Choi,. PEP-1-HO-1 prevents MPTP-induced degeneration of dopaminergic neurons in a Parkinson’s disease mouse model. BMB Rep 2014;47:569–574.
33. J.H.Lee, I.W.Kim, S.H.Kim, E.Y.Yun, S.H.Nam, M.Y.Ahn,. Anticancer activity of CopA3 dimer peptide in human gastric cancer cells. BMB Rep 2015;48:324–329.
34. S.H.Choi, B.K.Park, K.W.Lee, J.Chang, Y.Lee, H.J.Kwon Effect of respiratory syncytial virus on the growth of hepatocellular carcinoma cell-lines. BMB Rep 2015;48:565–570.
35. G.M.Uddin, C.Y.Kim, D.Chung, K.A.Kim, S.H.Jung One-step isolation of sappanol and brazilin from Caesalpinia sappan and their effects on oxidative stress-induced retinal death. BMB Rep 2015;48:289–294.
36. D.J.Kwon, Y.S.Bae, S.M.Ju, G.S.Youn, S.Y.Choi, J.Park Salicortin suppresses lipopolysaccharide-stimulated inflammatory responses via blockade of NF-κB and JNK activation in RAW 264.7 macrophages. BMB Rep 2014;47:318–323.
37. S.M.Ju, G.S.Youn, Y.S.Cho, S.Y.Choi, J.Park Celastrol ameliorates cytokine toxicity and pro-inflammatory immune responses by suppressing NF-κB activation in RINm5F beta cells. BMB Rep 2015;48:172–177.
38. E.Racker. Glutathione reductase from bakers’ yeast and beef liver. J Biol Chem 1995;217:855–865.
39. S.Rattanajarasroj, S.Unchern Comparable attenuation of Abeta(25–35)-induced neurotoxicity by quercitrin and 17beta-estradiol in cultured rat hippocampal neurons. Neurochem Res 2010;35:1196–1205.
40. A.Z.Reznick, L.Packer Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Meth Enzymol 1994;233:357–363.
41. R.Sultana, A.Ravagna, H.Mohmmad-Abdul, V.Calabrese, D.A.Butterfield Ferulic acid ethyl ester protects neurons against amyloid beta-peptide(1–42)-induced oxidative stress and neurotoxicity: relationship to antioxidant activity. J Neurochem 2005;92:749–758.
42. M.M.Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248–254.
43. +-associated mechanism. BMB Rep 2014;47:393–398.
44. L.Qin, Y.Liu, C.Cooper, B.Liu, B.Wilson, J.S.Hong. Microglia enhance beta-amyloid peptide-induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species. J Neurochem 2002;83:973–983.
45. P.Eikelenboom, W.A.Gool Neuroinflammatory perspectives on the two faces of Alzheimer’s disease. J Neural Transm (Vienna) 2004;111:281–294.
46. E.Turunc Bayrakdar, Y.Uyanikgil, L.Kanit, E.Koylu, A.Yalcin Nicotinamide treatment reduces the levels of oxidative stress, apoptosis, and PARP-1 activity in Aβ(1–42)-induced rat model of Alzheimer’s disease. Free Radic Res 2014;48:146–158.
47. A.Benazzouz, T.Boraud, P.Dubedat, A.Boireau, J.M.Stutzmann, C.Gross Riluzole prevents MPTP-induced parkinsonism in the rhesus monkey: a pilot study. Eur J Pharmacol 1995;284:299–307.
48. L.E.Keown, I.Collins, L.C.Cooper, T.Harrison, A.Madin, J.Mistry,. Novel orally bioavailable gamma-secretase inhibitors with excellent in vivo activity. J Med Chem 2009;52:3441–3444.
49. L.Cai, R.B.Innis, V.W.Pike Radioligand development for PET imaging of beta-amyloid (Abeta)–current status. Curr Med Chem 2007;14:19–52.
50. M.Biancalana, S.Koide Molecular mechanism of thioflavin-T binding to amyloid fibrils. Biochim Biophys Acta 2010;1804:1405–1412.
51. J.Geng, M.Li, L.Wu, J.Ren, X.Qu. Liberation of copper from amyloid plaques: making a risk factor useful for Alzheimer’s disease treatment. J Med Chem 2012;55:9146–9155.
52. C.Kim, D.W.Nam, S.Y.Park, H.Song, H.S.Hong, J.H.Boo,. O-linked β-N-acetylglucosaminidase inhibitor attenuates β-amyloid plaque and rescues memory impairment. Neurobiol Aging 2013;34:275–285.
53. S.Martire, A.Fuso, D.Rotili, I.Tempera, C.Giordano, I.De Zottis,. PARP-1 modulates amyloid beta peptide-induced neuronal damage. PLoS One 2013;8:e72169.
54. Y.Zou, B.Hong, L.Fan, L.Zhou, Y.Liu, Q.Wu, X.Zhang, M.Dong Protective effect of puerarin against beta-amyloid-induced oxidative stress in neuronal cultures from rat hippocampus: involvement of the GSK-3β/Nrf2 signaling pathway. Free Radic Res 2013;47:55–63.
55. K.Yuyama, H.Yamamoto, I.Nishizaki, T.Kato, I.Sora, T.Yamamoto Caspase-independent cell death by low concentrations of nitric oxide in PC12 cells: involvement of cytochrome C oxidase inhibition and the production of reactive oxygen species in mitochondria. J Neurosci Res 2003;3:351–363.
56. J.X.Chen, S.D.Yan Amyloid-beta-induced mitochondrial dysfunction. J Alzheimers Dis 2007;12:177–184.
57. H.Tayler, T.Fraser, J.S.Miners, P.G.Kehoe, S.Love Oxidative balance in Alzheimer’s disease: relationship to APOE, Braak tangle stage, and the concentrations of soluble and insoluble amyloid-β. J Alzheimers Dis 2010;22:1363–1373.
58. L.Wan, G.Nie, J.Zhang, Y.Luo, P.Zhang, Z.Zhang,. β-Amyloid peptide increases levels of iron content and oxidative stress in human cell and Caenorhabditis elegans models of Alzheimer disease. Free Radic Biol Med 2011;50:122–129.
59. G.A.Qureshi, S.Baig, M.Sarwar, S.H.Parvez Neurotoxicity, oxidative stress and cerebrovascular disorders. Neurotoxicology 2004;25;121–138.
60. A.J.Bruce-Keller, S.Gupta, T.E.Parrino, A.G.Knight, P.J.Ebenezer, A.M.Weidner,. NOX activity is increased in mild cognitive impairment. Antioxid Redox Signal 2010;12:1371–1382.
61. 25-35 induced ROS-burst through NADPH oxidase is sensitive to iron chelation in microglial Bv2 cells. Brain Res 2015;1629:282–290.
62. Y.Yao, J.Li, Y.Niu, J.Q.Yu, L.Yan, Z.H.Miao,. Resveratrol inhibits oligomeric Aβ-induced microglial activation via NADPH oxidase. Mol Med Rep 2015;12:6133–6139.
63. H.Possel, H.Noack, J.Putzke, G.Wolf, H.Sies Selective upregulation of inducible nitric oxide synthase (iNOS) by lipopolysaccharide (LPS) and cytokines in microglia: in vitro and in vivo studies. Glia 2000;32:51–59.
64. G.S.Prasath, C.S.Sundaram, S.P.Subramanian Fisetin averts oxidative stress in pancreatic tissues of streptozotocin-induced diabetic rats. Endocrine 2013;44:359–368.
65. C.Cecchi, S.Latorraca, S.Sorbi, T.Iantomasi, F.Favilli, M.T.Vincenzini, Gluthatione level is altered in lymphoblasts from patients with familial Alzheimer’s disease. Neurosci Lett 1999;275:152–154.
66. M.H.Li, J.H.Jang, B.Sun, Y.J.Surh Protective effects of oligomers of grape seed polyphenols against beta-amyloid-induced oxidative cell death. Ann NY Acad Sci2004;1030:317–329.
67. M.A.Smith, P.L.Richey Harris, L.M.Sayre, J.S.Beckman, G.Perry. Widespread peroxynitrite-mediated damage in Alzheimer’s disease. J Neurosci 1997;17:2653–2657.
68. K.Hensley, M.L.Maidt, Z.Yu, H.Sang, W.R.Markesbery, R.A.Floyd Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation. J Neurosci 1998;18:8126–8132.
69. A.Castegna, M.Aksenov, M.Aksenova, V.Thongboonkerd, J.B.Klein, W.M.Pierce,. Proteomic identification of oxidatively modified proteins in Alzheimer’s disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. Free Radic Biol Med 2002;33:562–571.
70. S.M.Yatin, S.Varadarajan, C.D.Link, D.A.Butterfield In vitro and in vivo oxidative stress associated with Alzheimer’s amyloidbeta-peptide (1–42). Neurobiol Aging 1999;20:325–330.
71. D.A.Butterfield, C.M.Lauderback Lipid peroxidation and protein oxidation in Alzheimer’s disease brain: potential causes and consequences involving amyloid beta-peptide associated free radical oxidative stress. Free Radic Biol Med 2002;32:1050–1060.